112 related articles for article (PubMed ID: 2117828)
1. Synthesis, oligomerization, and biological activity of the human immunodeficiency virus type 2 envelope glycoprotein expressed by a recombinant vaccinia virus.
Chakrabarti S; Mizukami T; Franchini G; Moss B
Virology; 1990 Sep; 178(1):134-42. PubMed ID: 2117828
[TBL] [Abstract][Full Text] [Related]
2. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Earl PL; Doms RW; Moss B
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):648-52. PubMed ID: 2300552
[TBL] [Abstract][Full Text] [Related]
3. Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41.
Jin Y; Giri C; Klutch MJ; Shepp D; Wright SE
Vaccine; 1993 Oct; 11(13):1280-2. PubMed ID: 8296479
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
Mulligan MJ; Ritter GD; Chaikin MA; Yamshchikov GV; Kumar P; Hahn BH; Sweet RW; Compans RW
Virology; 1992 Mar; 187(1):233-41. PubMed ID: 1736526
[TBL] [Abstract][Full Text] [Related]
5. A trans-dominant mutation in human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp41 inhibits membrane fusion when expressed in target cells.
Elson HF; Dimitrov DS; Blumenthal R
Mol Membr Biol; 1994; 11(3):165-9. PubMed ID: 7742881
[TBL] [Abstract][Full Text] [Related]
6. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein.
Earl PL; Moss B; Doms RW
J Virol; 1991 Apr; 65(4):2047-55. PubMed ID: 1900540
[TBL] [Abstract][Full Text] [Related]
7. Enhanced HIV-1 envelope-tumor protection by a recombinant vaccinia virus expressing anchored HIV-1 gp120 lacking gp41.
Lie H; Wright SE
Int J Mol Med; 1999 Apr; 3(4):397-400. PubMed ID: 10085412
[TBL] [Abstract][Full Text] [Related]
8. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
[TBL] [Abstract][Full Text] [Related]
9. Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding.
Murphy CI; Lennick M; Lehar SM; Beltz GA; Young E
Genet Anal Tech Appl; 1990 Oct; 7(6):160-71. PubMed ID: 2076345
[TBL] [Abstract][Full Text] [Related]
10. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
11. The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing.
Owens RJ; Compans RW
Virology; 1990 Dec; 179(2):827-33. PubMed ID: 2238472
[TBL] [Abstract][Full Text] [Related]
12. Mutation-directed chemical cross-linking of human immunodeficiency virus type 1 gp41 oligomers.
McInerney TL; El Ahmar W; Kemp BE; Poumbourios P
J Virol; 1998 Feb; 72(2):1523-33. PubMed ID: 9445056
[TBL] [Abstract][Full Text] [Related]
13. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
[TBL] [Abstract][Full Text] [Related]
14. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
Otteken A; Voss G; Hunsmann G
Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
[TBL] [Abstract][Full Text] [Related]
15. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane.
Jabbar MA; Nayak DP
J Virol; 1990 Dec; 64(12):6297-304. PubMed ID: 2243395
[TBL] [Abstract][Full Text] [Related]
16. Role of HIV-1 envelope V3 loop cleavage in cell tropism.
Gu R; Westervelt P; Ratner L
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.
Freed EO; Martin MA
J Virol; 1994 Apr; 68(4):2503-12. PubMed ID: 8139032
[TBL] [Abstract][Full Text] [Related]
18. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.
Earl PL; Koenig S; Moss B
J Virol; 1991 Jan; 65(1):31-41. PubMed ID: 1985202
[TBL] [Abstract][Full Text] [Related]
19. Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes.
McKenna PM; Pomerantz RJ; Dietzschold B; McGettigan JP; Schnell MJ
J Virol; 2003 Dec; 77(23):12782-94. PubMed ID: 14610200
[TBL] [Abstract][Full Text] [Related]
20. [HIV-1 env glycoprotein gp120 and gp160 expressed in vaccinia virus system and their antigenicity analysis].
Chen Y; Garcia R; Baralle FE
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):120-6. PubMed ID: 10453506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
